(Q46309286)

21 December 2017

title

Adiponectin levels are associated with coronary artery disease across Caucasian and African-American ethnicity (English)

1 reference

21 December 2017

main subject

coronary artery disease

1 reference

7

1 reference

21 December 2017

author name string

Guijing Lu

1

1 reference

21 December 2017

Alan Chiem

2

1 reference

21 December 2017

Erdembileg Anuurad

3

1 reference

21 December 2017

Peter J Havel

4

1 reference

21 December 2017

Thomas A Pearson

5

1 reference

21 December 2017

Bernard Ormsby

6

1 reference

21 December 2017

publication date

1 June 2007

1 reference

21 December 2017

published in

Translational Research

1 reference

21 December 2017

volume

149

1 reference

21 December 2017

issue

6

1 reference

21 December 2017

page(s)

317-323

1 reference

21 December 2017

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.12.008

Endogenous glucose production is inhibited by the adipose-derived protein Acrp30

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.12.008

Update on adipocyte hormones: regulation of energy balance and carbohydrate/lipid metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.12.008

Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.12.008

Association between dietary factors and plasma adiponectin concentrations in men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.12.008

Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.12.008

Adiponectin and adiponectin receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.12.008

Adiponectin as a biomarker of the metabolic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.12.008

Adiponectin: a key adipocytokine in metabolic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.12.008

Adiponectin and the development of type 2 diabetes: the atherosclerosis risk in communities study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.12.008

Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.12.008

Disruption of adiponectin causes insulin resistance and neointimal formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.12.008

Plasma adiponectin levels and risk of myocardial infarction in men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.12.008

Plasma adiponectin levels in overweight and obese Asians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.12.008

Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.12.008

Adiponectin and mortality in patients undergoing coronary angiography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.12.008

Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.12.008

Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.12.008

Risk factors for the metabolic syndrome: the Coronary Artery Risk Development in Young Adults (CARDIA) study, 1985-2001.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.12.008

Obesity, regional body fat distribution, and the metabolic syndrome in older men and women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.12.008

High levels of Lp(a) with a small apo(a) isoform are associated with coronary artery disease in African American and white men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.12.008

Plasma sphingomyelin level as a risk factor for coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.12.008

Protective effect of apolipoprotein E2 on coronary artery disease in African Americans is mediated through lipoprotein cholesterol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.12.008

Apo[a] size and PNR explain African American-Caucasian differences in allele-specific apo[a] levels for small but not large apo[a].

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.12.008

Hormonal regulation of lipoprotein(a) levels: effects of estrogen replacement therapy on lipoprotein(a) and acute phase reactants in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.12.008

Correct homeostasis model assessment (HOMA) evaluation uses the computer program

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.12.008

Insulin sensitivity at diagnosis of Type 2 diabetes is not associated with subsequent cardiovascular disease (UKPDS 67).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.12.008

Dyslipidemias with desirable plasma total cholesterol levels and angiographically demonstrated coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.12.008

Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.12.008

Ethnic differences in adiponectin levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.12.008

Hypoadiponectinaemia in South Asian women during pregnancy: evidence of ethnic variation in adiponectin concentration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.12.008

Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.12.008

Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.12.008

Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.12.008

Adiponectin and development of type 2 diabetes in the Pima Indian population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.12.008

Relation of Apo(a) size to carotid atherosclerosis in an elderly multiethnic population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.12.008

ApoE genotype affects allele-specific apo[a] levels for large apo[a] sizes in African Americans: the Harlem-Basset Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.12.008

Comparison of modifiable determinants of lipids and lipoprotein levels among African-Americans, Hispanics, and Non-Hispanic Caucasians > or =65 years of age living in New York City

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.12.008

10.1016/J.TRSL.2006.12.008

7 January 2021

Identifiers

DOI

1 reference

21 December 2017

1 reference

21 December 2017